HOLOGIC, INC. (NASDAQ:HOLX) Files An 8-K Submission of Matters to a Vote of Security Holders
Item 5.07
Submission of Matters to a Vote of Security Holders.
The Company’s Annual Meeting of Stockholders was held on March 7, 2019. Of the 267,515,965 shares outstanding and entitled to vote, 251,644,732 shares were represented at the meeting, constituting a quorum of 94.06%
All eight director nominees were elected to the Board for a one-year term.
In addition to electing directors, the stockholders:
|
provided advisory approval of the Company’s executive compensation (“say-on-pay”); and |
|
ratified the selection of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending September 28, 2019. |
The results of the votes for each of these proposals were as follows:
Proposal 1. Election of Directors
|
Nominees |
For |
Withhold |
Broker Non-Votes |
|
Stephen P. MacMillan |
237,093,518 |
4,007,529 |
10,543,685 |
|
Sally W. Crawford |
221,784,690 |
19,316,357 |
10,543,685 |
|
Charles J. Dockendorff |
239,078,159 |
2,022,888 |
10,543,685 |
|
Scott T. Garrett |
221,175,933 |
19,925,114 |
10,543,685 |
|
Ludwig N. Hantson |
224,522,309 |
16,578,738 |
10,543,685 |
|
Namal Nawana |
224,145,567 |
16,955,480 |
10,543,685 |
|
Christiana Stamoulis |
240,592,669 |
508,378 |
10,543,685 |
|
Amy M. Wendell |
240,787,975 |
313,072 |
10,543,685 |
Proposal 2. Advisory approval of the Company’s executive compensation
|
For: |
Against: |
Abstain: |
Broker Non-Votes: |
|
158,018,788 |
82,762,537 |
319,722 |
10,543,685 |
|
Proposal 3. |
Ratification of the selection of Ernst & Young LLP as the Company’s independent auditors for the fiscal year ending September 28, 2019 |
|
For: |
Against: |
Abstain: |
|
249,279,863 |
2,141,805 |
223,064 |
About HOLOGIC, INC. (NASDAQ:HOLX)
Hologic, Inc. is a developer, manufacturer and supplier of diagnostics products, medical imaging systems and surgical products with an emphasis on women’s health. The Company operates through four segments: Diagnostics, Breast Health, GYN Surgical and Skeletal Health. The diagnostics products include Aptima family of assays, ThinPrep system, the Rapid Fetal Fibronectin Test and Procleix blood screening assays. It offers viral load assays for the quantitation of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus-1 (HIV-1). The Breast Health products include breast imaging and related products and accessories, including digital mammography systems, computer-aided detection (CAD) and breast biopsy guidance systems. The GYN Surgical products include NovaSure Endometrial Ablation System and MyoSure Hysteroscopic Tissue Removal System. The Skeletal Health segment offers Discovery and Horizon X-ray bone densitometers and mini C-arm imaging systems.
